Abstract
Neurofibromatosis type 1 (NF1) is an autosomal-dominant neurocutaneous syndrome affecting various parts of the body, including the renovascular and urinary systems. We evaluated the renovascular, urinary, glomerular, and tubular functions of children with NF1. We compared blood pressures, urinary findings, and renal glomerular and tubular functions in children with NF1 with those of a healthy age- and gender-matched control group. We evaluated 46 NF1 patients and 33 healthy controls. The mean ages of the NF1 group (female/male: 20/26) and the control group (female/male: 15/18) were 10.1 ± 4.6 and 10.6 ± 4.3 years respectively. Six NF1 patients were hypertensive. The mean blood pressures of the NF1 group were significantly higher than those of the control group. Renal artery stenosis was detected in one NF1 patient. Urinary tract anomalies were evident in 21.7% of NF1 but only 9% of control subjects. The mean estimated glomerular filtration rate (eGFR) of the NF1 group was significantly lower than that of the control group. Six NF1 patients evidenced eGFRs < 90 mL/min. In the NF1 group, tubular phosphorus reabsorption was significantly lower and uric acid excretion significantly higher than in the control group.
Conclusion: Hypertension, urinary tract anomalies, and impaired renal function were more common in NF1 patients than healthy controls. Regular blood pressure measurements and evaluation of urinary tract and kidney function are essential for NF1 patients.
What is Known: • NF1 is most commonly associated with systemic hypertension due to renal artery vasculopathy and the development of a pheochromocytoma. • Hydronephrosis and bladder involvement have been documented in NF1. | |
What is New: • Renal glomerular and tubular functions may be affected in NF1. |
Similar content being viewed by others
Data availability
Our data and material is available.
Code availability
Not applicable.
Abbreviations
- CT:
-
Computerized tomography
- DMSA:
-
Dimercaptosuccinic acid
- eGFR:
-
Estimated glomerular filtration rate
- FeK:
-
Fractional excretion of potassium
- FeNa:
-
Fractional excretion of sodium
- FeMg:
-
Fractional excretion of magnesium
- FeUA:
-
Fractional excretion of uric acid
- NF1:
-
Neurofibromatosis type 1
- MR:
-
Magnetic resonance
- SD:
-
Standard deviation
- TRP:
-
Tubular reabsorption of phosphorus
References
Hirbe AC, Gutmann DH (2014) Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol 13:834–843. https://doi.org/10.1016/S1474-4422(14)70063-8
Weiss B, Bollag G, Shannon K (1999) Hyperactive Ras as a therapeutic target in neurofibromatosis type 1. Am J Med Genet 89:14–22
Ly KI, Blakeley JO (2019) The diagnosis and management of neurofibromatosis type 1. Med Clin North Am 103:1035–1054. https://doi.org/10.1016/j.mcna.2019.07.004
Friedman JM, Arbiser J, Epstein JA, Gutmann DH, Huot SJ, Lin AE, Mcmanus B, Korf BR (2002) Cardiovascular disease in neurofibromatosis 1: report of the NF1 cardiovascuar task force. Genet Med 4:105–111
Oderich GS, Sullivan TM, Bower TC, Gloviczki P, Miller DV, Babovic-Vuksanovic D, Macedo TA, Stanson A (2007) Vascular abnormalities in patients with neurofibromatosis syndrome type 1: clinical spectrum, management and results. J Vasc Surg 46:475–484
Norton KK, Xu J, Guttman DH (1995) Expression of the neurofibromatosis 1 gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle. Neurobiol Dis 2:13–21
Jouhilahti EM, Peltonen S, Heape AM, Peltonen J (2011) The pathoetiology of neurofibromatosis 1. Am J Pathol 178:1932–1939
Pycha A, Klingler CH, Reiter WJ, Schroth B, Haitel A, Latal D (2001) Von Recklinghausen neurofibromatosis with urinary bladder involvement. Urology 58:106
Kaefer M, Adams MC, Rink RC, Keating MA (1997) Principles in management of complex pediatric genitourinary plexiform neurofibroma. Urology 49:936–940
Kaas B, Huisman TA, Tekes A et al (2013) Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1. J Child Neurol 28:561–569
Kokubo T, Hiki Y, Horii A, Kobayashi Y (1993) Recklinghausen’s neurofibromatosis associated with membranous nephropathy. Nephron 1993 65:486. https://doi.org/10.1159/000187543
Lin F, Zhang D, Chang J, Tang X, Guan W, Jiang G, Zhu C, Bian F (2018) THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1. Eur J Med Genet 61:84–88. https://doi.org/10.1016/j.ejmg.2017.10.014
Tóth T, Trinn C, Simon L, Nagy J (1996) A case of membranous glomerulonephritis associated with Recklinghausen’s neurofibromatosis. Clin Nephrol 45:271–272
Wani MM, Reshi AR, Banday KA, Najar MS (2006) von Recklinghausen’s neurofibromatosis associated with membranous glomerulonephritis. Saudi Med J 27:534–535
Taniguchi Y, Yorioka N, Kanbe M, Okushin S, Oda H, Nishida Y, Kushihata S&;, Murakami I, Yamakido M (1997) Parent and child cases of IgA nephropathy associated with von Recklinghausen’s disease. Nephron 75:113–114. https://doi.org/10.1159/000189515
Van-Gils J, Harambat J, Jubert C et al (2014) Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link? Eur J Med Genet 57:639–642. https://doi.org/10.1016/j.ejmg.2014.09.001
Tarrass F (2008) Focal and segmental glomerulosclerosis and von Recklinghausen’s neurofibromatosis: coincidental or associated? Saudi J Kidney Dis Transpl 19:453–454
Gersch MS, Talor Z (2006) Focal segmental glomerular sclerosis in a patient with neurofibromatosis type I. Am J Kidney Dis 47:e17–e19. https://doi.org/10.1053/j.ajkd.2005.09.017
Orera A, Lacarra S, Fernández L, Gómez N, Slon MF, Manrique J (2019) Síndrome nefrótico secundario en neurofibromatosis tipo 1. A propósito de dos casos [Secondary glomerulonephritis in neurofibromatosis type 1. Two case reports]. An Sist Sanit Navar 42:345–349. https://doi.org/10.23938/ASSN.0720
Khan U, Razdan R, Perazella MA (2013) Anuric acute kidney injury in neurofibromatosis 1. Am J Kidney Dis 61:519–522. https://doi.org/10.1053/j.ajkd.2012.08.044
Yılmaz K, Dusunsel R, Dursun I, Coskun A, Erten S, Kucukaydın M, Yel S, Gunduz Z (2013) Neurofibromas of the bladder in a child with neurofibromatosis type 1 causing chronic renal disease. Ren Fail 35:1005–1007. https://doi.org/10.3109/0886022X.2013.809004
DeBella K, Szudek J, Friedman JM (2000) Use of the national institutes of health criteria for diagnosis of neurofibromatosis1 in children. Pediatrics 105:608–614
Flynn JT, Kaelber DC, Baker-Smith CM et al (2017) Subcommittee on screening and management of high blood pressure in children. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 140:e20173035
Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263
Patel PA, Cahill AM (2021) Renovascular hypertension in children. CVIR Endovasc 7(4):10. https://doi.org/10.1186/s42155-020-00176-5
Estepa R, Gallego N, Orte L, Puras E, Aracil E, Ortuño J (2001) Renovascular hypertension in children. Scand J Urol Nephrol 35:388–392. https://doi.org/10.1080/003655901753224459
Dubov T, Alhadef HT, Chernin G, Constantini S, Cleper R, Shachar SB (2016) High prevalence of elevated blood pressure among children with neurofibromatosis type 1. Pediatr Nephrol 31:131–136
Duan L, Feng K, Tong A, Liang Z (2014) Renal artery stenosis due to neurofibromatosis type 1: case report and literature review. Eur J Med Res 28(19):17. https://doi.org/10.1186/2047-783X-19-17
Stabouli S, Vargiami E, Maliachova et al (2018) Arterial stiffness in a toddler with neurofibromatosis type 1 and refractory hypertension. Case Rep Pediatr 31:5957987–5957984. https://doi.org/10.1155/2018/5957987
Lee ML, Chang TM, Yang RC, Yang AD, Chen M (2019) Systemic hypertension followed by insidious stroke in a 12-year-old boy with childhood neurofibromatosis type 1 presenting with renal and cerebral artery vasculopathy. Turk J Pediatr 61:629–634. https://doi.org/10.24953/turkjped.2019.04.026
Fossali E, Signorini E, İntermite RC et al (2000) Renovascular disease and hypertension in children with neurofibromatosis. Pediatr Nephrol 14:806–810
Leppӓvirta J, Kallionpӓӓ RA, Uusitalo E et al (2018) Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study. Orphanet J Rare Dis 13:5
Senel S, Erkek N, Karacan CD (2010) Neurofibromatosis type 1 with idiopathic hypercalciuria, nephrolithiasis and horshoe kidney. Pediatr Nephrol 25:1575–1576
Jat KR, Marwaha RK, Panigrahi I, Gupta V (2008) Neurofibromatosis type 1 with intracranial hemorrhage and horseshoe kidney. Pediatr Neurol 2008 39:295–297. https://doi.org/10.1016/j.pediatrneurol.2008.07.009
Chen MH, Chen KS, Hou JW, Lee CC, Huang JS (2002) Coexistence of autosomal dominant polycystic kidney disease and neurofibromatosis: report of a family. Am J Nephrol 22:376–380. https://doi.org/10.1159/000065231
Peces R, Mena R, Martín Y, Hernández C, Peces C, Tellería D, Cuesta E, Selgas R, Lapunzina P, Nevado J (2020) Co-occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2. Mol Genet Genomic Med 8:e1321. https://doi.org/10.1002/mgg3.1321
Varyani UT, Shah NM, Shah PR, Kute VB, Balwani MR, Trivedi HL (2019) C1q nephropathy in a patient of neurofibromatosis type 1: a rare case report. Indian J Nephrol 29:125–127. https://doi.org/10.4103/ijn.IJN_353_17
Ali US (2011) Joubert syndrome with nephronophthisis in neurofibromatosis type 1. Saudi J Kidney Dis Transpl 22:788–791
Bouty A, Dobremez E, Harper L, Harambat J, Bouteiller C, Zaghet B, Wolkenstein P, Ducassou S, Lefevre Y (2018) Bladder dysfunction in children with neurofibromatosis type I: report of four cases and review of the literature. Urol Int 100:339–345. https://doi.org/10.1159/000487193
Diplomatico M, Marzuillo P, La Manna A, Apicella A, Guarino S, Piccolo V (2020) From skin to kidneys: cutaneous clues of renal disease in children. Dermatol Pract Concept 26:e2020095. https://doi.org/10.5826/dpc.1004a95
Stay EJ, Vawter G (1977) The relationship between nephroblastoma and neurofibromatosis (Von Recklinghausen’s disease). Cancer 39:2550–2555. https://doi.org/10.1002/1097-0142(197706)39:6<2550::aid-cncr2820390636>3.0.co;2-y
Stone NN, Atlas I, Kim US, Kwan D, Leventhal I, Waxman JS (1993) Renal angiomyolipoma associated with neurofibromatosis and primary carcinoid of mesentery. Urology 41:66–71. https://doi.org/10.1016/0090-4295(93)90249-a
Nguyen KT, Chiu M (2008) Segmental neurofibromatosis associated with renal angiomyolipomas. Cutis 82:65–68
Iarrobino G, Capasso L, Buonincontro S, Alderisio A, Sciano D, Calabrese R, Borsi E (2008) Chirurgia conservativa del parenchima renale per angiomiolipoma emorragico: due casi clinici [Preservative surgery of the kidney for haemorrhagic angiomyolipoma: a report of two cases]. Chir Ital 60:587–593
Korkiamäki T, Ylä-Outinen H, Leinonen P, Koivunen J, Peltonen J (2005) The effect of extracellular calcium concentration on calcium-mediated cell signaling in NF1 tumor suppressor-deficient keratinocytes. Arch Dermatol Res 296:465–472. https://doi.org/10.1007/s00403-004-0538-4
Wang Y, Brittain JM, Wilson SM, Hingtgen CM, Khanna R (2010) Altered calcium currents and axonal growth in NF1 haploinsufficient mice. Transl Neurosci 1:106–114. https://doi.org/10.2478/v10134-010-0025-8
Author information
Authors and Affiliations
Contributions
OYA, BÇ, and FB were the major contributors in writing the manuscript. BÇ, FB, and HGP were involved in the collection of the data and the clinical follow-up of the patients. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
The approval of the Local Ethical Committee was obtained (Kayseri City Education and Research Hospital).
Consent to participate
Informed consent was obtained from all parents of the children.
Consent for publication
Consents for publication were obtained from the participants.
Conflict of interest
The authors declare no competing interests.
Additional information
Communicated by Gregorio Paolo Milani
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Celik, B., Aksoy, O.Y., Bastug, F. et al. Renal manifestations in children with neurofibromatosis type 1. Eur J Pediatr 180, 3477–3482 (2021). https://doi.org/10.1007/s00431-021-04144-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-021-04144-6